APO Research, Inc.

APO RESEARCH · REPORT

Qi-Tonifying Chinese Medicine Injections

Selected research

Market Outlook & Growth Opportunities

Global Qi-Tonifying Chinese Medicine Injections Market Outlook and Growth Opportunities 2026

Market perspective

The global Qi-Tonifying Chinese Medicine Injections market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Qi-Tonifying Chinese Medicine Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Qi-Tonifying Chinese Medicine Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Qi-Tonifying Chinese Medicine Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Qi-Tonifying Chinese Medicine Injections market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Qi-Tonifying Chinese Medicine Injections market include Chiatai Qingchunbao Pharmaceutical, ZBD Pharmaceutical, Jilin Jian Yisheng Pharmaceutical, Suzhong Pharmaceutical Group, Shineway Pharmaceutical, China Resources Sanjiu, Sinopharm Yibin Pharmaceutical, Dali Pharmaceutical and Changshu Leiyunshang Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Qi-Tonifying Chinese Medicine Injections market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Qi-Tonifying Chinese Medicine Injections and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Qi-Tonifying Chinese Medicine Injections sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Qi-Tonifying Chinese Medicine Injections market size, projected growth trends, production technologies, key applications, and end-use industries.

Qi-Tonifying Chinese Medicine Injections Segment by Company

Chiatai Qingchunbao Pharmaceutical

ZBD Pharmaceutical

Jilin Jian Yisheng Pharmaceutical

Suzhong Pharmaceutical Group

Shineway Pharmaceutical

China Resources Sanjiu

Sinopharm Yibin Pharmaceutical

Dali Pharmaceutical

Changshu Leiyunshang Pharmaceutical

Qi-Tonifying Chinese Medicine Injections Segment by Type

Shengmai Injection

Astragalus Injection

Other

Qi-Tonifying Chinese Medicine Injections Segment by Application

Secondary Hospital

Tertiary Hospital

Other

Qi-Tonifying Chinese Medicine Injections Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Qi-Tonifying Chinese Medicine Injections status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Qi-Tonifying Chinese Medicine Injections market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Qi-Tonifying Chinese Medicine Injections significant trends, drivers, influence factors in global and regions.

6. To analyze Qi-Tonifying Chinese Medicine Injections competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Qi-Tonifying Chinese Medicine Injections market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Qi-Tonifying Chinese Medicine Injections and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Qi-Tonifying Chinese Medicine Injections.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Qi-Tonifying Chinese Medicine Injections market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Qi-Tonifying Chinese Medicine Injections industry.

Chapter 3: Detailed analysis of Qi-Tonifying Chinese Medicine Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Qi-Tonifying Chinese Medicine Injections in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Qi-Tonifying Chinese Medicine Injections in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Qi-Tonifying Chinese Medicine Injections Industry Trends Table 2. Qi-Tonifying Chinese Medicine Injections Industry Drivers Table 3. Qi-Tonifying Chinese Medicine Injections Industry Opportunities and Challenges Table 4. Qi-Tonifying Chinese Medicine Injections Industry Restraints Table 5. Global Qi-Tonifying Chinese Medicine Injections Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Qi-Tonifying Chinese Medicine Injections Revenue Share by Company (2021-2026) Table 7. Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Company (k units) & (2021-2026) Table 8. Global Qi-Tonifying Chinese Medicine Injections Sales Volume Share by Company (2021-2026) Table 9. Global Qi-Tonifying Chinese Medicine Injections Average Price (USD/unit) of Company (2021-2026) Table 10. Global Qi-Tonifying Chinese Medicine Injections Company Ranking, (2024-2026) & (USD Million) Table 11. Global Qi-Tonifying Chinese Medicine Injections Key Company Manufacturing Base & Headquarters Table 12. Global Qi-Tonifying Chinese Medicine Injections Company, Product Type & Application Table 13. Global Qi-Tonifying Chinese Medicine Injections Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Qi-Tonifying Chinese Medicine Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Shengmai Injection Table 18. Significant Companies of Astragalus Injection Table 19. Significant Companies of Other Table 20. Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Type (2021-2026) & (k units) Table 22. Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Type (2027-2032) & (k units) Table 23. Global Qi-Tonifying Chinese Medicine Injections Sales Volume Share by Type (2021-2026) Table 24. Global Qi-Tonifying Chinese Medicine Injections Sales Volume Share by Type (2027-2032) Table 25. Global Qi-Tonifying Chinese Medicine Injections Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Qi-Tonifying Chinese Medicine Injections Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Qi-Tonifying Chinese Medicine Injections Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type (2021-2026) Table 29. Global Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Secondary Hospital Table 31. Significant Companies of Tertiary Hospital Table 32. Significant Companies of Other Table 33. Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Application (2021-2026) & (k units) Table 35. Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Application (2027-2032) & (k units) Table 36. Global Qi-Tonifying Chinese Medicine Injections Sales Volume Share by Application (2021-2026) Table 37. Global Qi-Tonifying Chinese Medicine Injections Sales Volume Share by Application (2027-2032) Table 38. Global Qi-Tonifying Chinese Medicine Injections Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Qi-Tonifying Chinese Medicine Injections Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Qi-Tonifying Chinese Medicine Injections Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application (2021-2026) Table 42. Global Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application (2027-2032) Table 43. Global Qi-Tonifying Chinese Medicine Injections Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Qi-Tonifying Chinese Medicine Injections Sales by Region (2021-2026) & (k units) Table 45. Global Qi-Tonifying Chinese Medicine Injections Sales Market Share by Region (2021-2026) Table 46. Global Qi-Tonifying Chinese Medicine Injections Sales by Region (2027-2032) & (k units) Table 47. Global Qi-Tonifying Chinese Medicine Injections Sales Market Share by Region (2027-2032) Table 48. Global Qi-Tonifying Chinese Medicine Injections Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Qi-Tonifying Chinese Medicine Injections Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Qi-Tonifying Chinese Medicine Injections Sales Value Share by Region (2021-2026) Table 51. Global Qi-Tonifying Chinese Medicine Injections Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Qi-Tonifying Chinese Medicine Injections Sales Value Share by Region (2027-2032) Table 53. Global Qi-Tonifying Chinese Medicine Injections Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Qi-Tonifying Chinese Medicine Injections Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Qi-Tonifying Chinese Medicine Injections Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Qi-Tonifying Chinese Medicine Injections Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Qi-Tonifying Chinese Medicine Injections Sales by Country (2021-2026) & (k units) Table 58. Global Qi-Tonifying Chinese Medicine Injections Sales Market Share by Country (2021-2026) Table 59. Global Qi-Tonifying Chinese Medicine Injections Sales by Country (2027-2032) & (k units) Table 60. Global Qi-Tonifying Chinese Medicine Injections Sales Market Share by Country (2027-2032) Table 61. Global Qi-Tonifying Chinese Medicine Injections Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Qi-Tonifying Chinese Medicine Injections Sales Value Market Share by Country (2021-2026) Table 63. Global Qi-Tonifying Chinese Medicine Injections Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Qi-Tonifying Chinese Medicine Injections Sales Value Market Share by Country (2027-2032) Table 65. Chiatai Qingchunbao Pharmaceutical Company Information Table 66. Chiatai Qingchunbao Pharmaceutical Business Overview Table 67. Chiatai Qingchunbao Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Chiatai Qingchunbao Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio Table 69. Chiatai Qingchunbao Pharmaceutical Recent Development Table 70. ZBD Pharmaceutical Company Information Table 71. ZBD Pharmaceutical Business Overview Table 72. ZBD Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. ZBD Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio Table 74. ZBD Pharmaceutical Recent Development Table 75. Jilin Jian Yisheng Pharmaceutical Company Information Table 76. Jilin Jian Yisheng Pharmaceutical Business Overview Table 77. Jilin Jian Yisheng Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Jilin Jian Yisheng Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio Table 79. Jilin Jian Yisheng Pharmaceutical Recent Development Table 80. Suzhong Pharmaceutical Group Company Information Table 81. Suzhong Pharmaceutical Group Business Overview Table 82. Suzhong Pharmaceutical Group Qi-Tonifying Chinese Medicine Injections Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Suzhong Pharmaceutical Group Qi-Tonifying Chinese Medicine Injections Product Portfolio Table 84. Suzhong Pharmaceutical Group Recent Development Table 85. Shineway Pharmaceutical Company Information Table 86. Shineway Pharmaceutical Business Overview Table 87. Shineway Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Shineway Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio Table 89. Shineway Pharmaceutical Recent Development Table 90. China Resources Sanjiu Company Information Table 91. China Resources Sanjiu Business Overview Table 92. China Resources Sanjiu Qi-Tonifying Chinese Medicine Injections Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. China Resources Sanjiu Qi-Tonifying Chinese Medicine Injections Product Portfolio Table 94. China Resources Sanjiu Recent Development Table 95. Sinopharm Yibin Pharmaceutical Company Information Table 96. Sinopharm Yibin Pharmaceutical Business Overview Table 97. Sinopharm Yibin Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Sinopharm Yibin Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio Table 99. Sinopharm Yibin Pharmaceutical Recent Development Table 100. Dali Pharmaceutical Company Information Table 101. Dali Pharmaceutical Business Overview Table 102. Dali Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Dali Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio Table 104. Dali Pharmaceutical Recent Development Table 105. Changshu Leiyunshang Pharmaceutical Company Information Table 106. Changshu Leiyunshang Pharmaceutical Business Overview Table 107. Changshu Leiyunshang Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Changshu Leiyunshang Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio Table 109. Changshu Leiyunshang Pharmaceutical Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Qi-Tonifying Chinese Medicine Injections Distributors List Table 113. Qi-Tonifying Chinese Medicine Injections Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Qi-Tonifying Chinese Medicine Injections Product Image Figure 2. Global Qi-Tonifying Chinese Medicine Injections Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Qi-Tonifying Chinese Medicine Injections Sales Value (2021-2032) & (US$ Million) Figure 4. Global Qi-Tonifying Chinese Medicine Injections Sales (2021-2032) & (k units) Figure 5. Global Qi-Tonifying Chinese Medicine Injections Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Qi-Tonifying Chinese Medicine Injections Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Shengmai Injection Image Figure 10. Astragalus Injection Image Figure 11. Other Image Figure 12. Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Qi-Tonifying Chinese Medicine Injections Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Qi-Tonifying Chinese Medicine Injections Sales Volume Share by Type (2021-2032) Figure 15. Global Qi-Tonifying Chinese Medicine Injections Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Qi-Tonifying Chinese Medicine Injections Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type (2021-2032) Figure 18. Secondary Hospital Image Figure 19. Tertiary Hospital Image Figure 20. Other Image Figure 21. Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Qi-Tonifying Chinese Medicine Injections Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Qi-Tonifying Chinese Medicine Injections Sales Volume Share by Application (2021-2032) Figure 24. Global Qi-Tonifying Chinese Medicine Injections Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Qi-Tonifying Chinese Medicine Injections Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application (2021-2032) Figure 27. Global Qi-Tonifying Chinese Medicine Injections Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Qi-Tonifying Chinese Medicine Injections Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Qi-Tonifying Chinese Medicine Injections Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Qi-Tonifying Chinese Medicine Injections Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Qi-Tonifying Chinese Medicine Injections Sales Value (2021-2032) & (US$ Million) Figure 32. North America Qi-Tonifying Chinese Medicine Injections Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Qi-Tonifying Chinese Medicine Injections Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Qi-Tonifying Chinese Medicine Injections Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Qi-Tonifying Chinese Medicine Injections Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Qi-Tonifying Chinese Medicine Injections Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Qi-Tonifying Chinese Medicine Injections Sales Value (2021-2032) & (US$ Million) Figure 38. South America Qi-Tonifying Chinese Medicine Injections Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Qi-Tonifying Chinese Medicine Injections Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Qi-Tonifying Chinese Medicine Injections Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Qi-Tonifying Chinese Medicine Injections Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Qi-Tonifying Chinese Medicine Injections Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Shengmai Injection
  • Astragalus Injection
  • Other
Applications
  • Secondary Hospital
  • Tertiary Hospital
  • Other
Companies covered
  • Chiatai Qingchunbao Pharmaceutical
  • ZBD Pharmaceutical
  • Jilin Jian Yisheng Pharmaceutical
  • Suzhong Pharmaceutical Group
  • Shineway Pharmaceutical
  • China Resources Sanjiu
  • Sinopharm Yibin Pharmaceutical
  • Dali Pharmaceutical
  • Changshu Leiyunshang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Qi-Tonifying Chinese Medicine Injections Sales Value (2021-2032)
  4. 1.2.2 Global Qi-Tonifying Chinese Medicine Injections Sales Volume (2021-2032)
  5. 1.2.3 Global Qi-Tonifying Chinese Medicine Injections Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Qi-Tonifying Chinese Medicine Injections Market Dynamics
  1. 2.1 Qi-Tonifying Chinese Medicine Injections Industry Trends
  2. 2.2 Qi-Tonifying Chinese Medicine Injections Industry Drivers
  3. 2.3 Qi-Tonifying Chinese Medicine Injections Industry Opportunities and Challenges
  4. 2.4 Qi-Tonifying Chinese Medicine Injections Industry Restraints
3 Qi-Tonifying Chinese Medicine Injections Market by Company
  1. 3.1 Global Qi-Tonifying Chinese Medicine Injections Company Revenue Ranking in 2025
  2. 3.2 Global Qi-Tonifying Chinese Medicine Injections Revenue by Company (2021-2026)
  3. 3.3 Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Company (2021-2026)
  4. 3.4 Global Qi-Tonifying Chinese Medicine Injections Average Price by Company (2021-2026)
  5. 3.5 Global Qi-Tonifying Chinese Medicine Injections Company Ranking (2024-2026)
  6. 3.6 Global Qi-Tonifying Chinese Medicine Injections Company Manufacturing Base and Headquarters
  7. 3.7 Global Qi-Tonifying Chinese Medicine Injections Company Product Type and Application
  8. 3.8 Global Qi-Tonifying Chinese Medicine Injections Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Qi-Tonifying Chinese Medicine Injections Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Qi-Tonifying Chinese Medicine Injections Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Qi-Tonifying Chinese Medicine Injections Market by Type
  1. 4.1 Qi-Tonifying Chinese Medicine Injections Type Introduction
  2. 4.1.1 Shengmai Injection
  3. 4.1.2 Astragalus Injection
  4. 4.1.3 Other
  5. 4.2 Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Type
  6. 4.2.1 Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Qi-Tonifying Chinese Medicine Injections Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Qi-Tonifying Chinese Medicine Injections Sales Value by Type
  10. 4.3.1 Global Qi-Tonifying Chinese Medicine Injections Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Qi-Tonifying Chinese Medicine Injections Sales Value by Type (2021-2032)
  12. 4.3.3 Global Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type (2021-2032)
5 Qi-Tonifying Chinese Medicine Injections Market by Application
  1. 5.1 Qi-Tonifying Chinese Medicine Injections Application Introduction
  2. 5.1.1 Secondary Hospital
  3. 5.1.2 Tertiary Hospital
  4. 5.1.3 Other
  5. 5.2 Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Application
  6. 5.2.1 Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Qi-Tonifying Chinese Medicine Injections Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Qi-Tonifying Chinese Medicine Injections Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Qi-Tonifying Chinese Medicine Injections Sales Value by Application
  10. 5.3.1 Global Qi-Tonifying Chinese Medicine Injections Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Qi-Tonifying Chinese Medicine Injections Sales Value by Application (2021-2032)
  12. 5.3.3 Global Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application (2021-2032)
6 Qi-Tonifying Chinese Medicine Injections Regional Sales and Value Analysis
  1. 6.1 Global Qi-Tonifying Chinese Medicine Injections Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Qi-Tonifying Chinese Medicine Injections Sales by Region (2021-2032)
  3. 6.2.1 Global Qi-Tonifying Chinese Medicine Injections Sales by Region: 2021-2026
  4. 6.2.2 Global Qi-Tonifying Chinese Medicine Injections Sales by Region (2027-2032)
  5. 6.3 Global Qi-Tonifying Chinese Medicine Injections Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Qi-Tonifying Chinese Medicine Injections Sales Value by Region (2021-2032)
  7. 6.4.1 Global Qi-Tonifying Chinese Medicine Injections Sales Value by Region: 2021-2026
  8. 6.4.2 Global Qi-Tonifying Chinese Medicine Injections Sales Value by Region (2027-2032)
  9. 6.5 Global Qi-Tonifying Chinese Medicine Injections Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Qi-Tonifying Chinese Medicine Injections Sales Value (2021-2032)
  12. 6.6.2 North America Qi-Tonifying Chinese Medicine Injections Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Qi-Tonifying Chinese Medicine Injections Sales Value (2021-2032)
  15. 6.7.2 Europe Qi-Tonifying Chinese Medicine Injections Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Qi-Tonifying Chinese Medicine Injections Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Qi-Tonifying Chinese Medicine Injections Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Qi-Tonifying Chinese Medicine Injections Sales Value (2021-2032)
  21. 6.9.2 South America Qi-Tonifying Chinese Medicine Injections Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Qi-Tonifying Chinese Medicine Injections Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Qi-Tonifying Chinese Medicine Injections Sales Value Share by Country, 2025 VS 2032
7 Qi-Tonifying Chinese Medicine Injections Country-level Sales and Value Analysis
  1. 7.1 Global Qi-Tonifying Chinese Medicine Injections Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Qi-Tonifying Chinese Medicine Injections Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Qi-Tonifying Chinese Medicine Injections Sales by Country (2021-2032)
  4. 7.3.1 Global Qi-Tonifying Chinese Medicine Injections Sales by Country (2021-2026)
  5. 7.3.2 Global Qi-Tonifying Chinese Medicine Injections Sales by Country (2027-2032)
  6. 7.4 Global Qi-Tonifying Chinese Medicine Injections Sales Value by Country (2021-2032)
  7. 7.4.1 Global Qi-Tonifying Chinese Medicine Injections Sales Value by Country (2021-2026)
  8. 7.4.2 Global Qi-Tonifying Chinese Medicine Injections Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Qi-Tonifying Chinese Medicine Injections Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Qi-Tonifying Chinese Medicine Injections Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Qi-Tonifying Chinese Medicine Injections Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chiatai Qingchunbao Pharmaceutical
  2. 8.1.1 Chiatai Qingchunbao Pharmaceutical Company Information
  3. 8.1.2 Chiatai Qingchunbao Pharmaceutical Business Overview
  4. 8.1.3 Chiatai Qingchunbao Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chiatai Qingchunbao Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio
  6. 8.1.5 Chiatai Qingchunbao Pharmaceutical Recent Developments
  7. 8.2 ZBD Pharmaceutical
  8. 8.2.1 ZBD Pharmaceutical Company Information
  9. 8.2.2 ZBD Pharmaceutical Business Overview
  10. 8.2.3 ZBD Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ZBD Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio
  12. 8.2.5 ZBD Pharmaceutical Recent Developments
  13. 8.3 Jilin Jian Yisheng Pharmaceutical
  14. 8.3.1 Jilin Jian Yisheng Pharmaceutical Company Information
  15. 8.3.2 Jilin Jian Yisheng Pharmaceutical Business Overview
  16. 8.3.3 Jilin Jian Yisheng Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Jilin Jian Yisheng Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio
  18. 8.3.5 Jilin Jian Yisheng Pharmaceutical Recent Developments
  19. 8.4 Suzhong Pharmaceutical Group
  20. 8.4.1 Suzhong Pharmaceutical Group Company Information
  21. 8.4.2 Suzhong Pharmaceutical Group Business Overview
  22. 8.4.3 Suzhong Pharmaceutical Group Qi-Tonifying Chinese Medicine Injections Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Suzhong Pharmaceutical Group Qi-Tonifying Chinese Medicine Injections Product Portfolio
  24. 8.4.5 Suzhong Pharmaceutical Group Recent Developments
  25. 8.5 Shineway Pharmaceutical
  26. 8.5.1 Shineway Pharmaceutical Company Information
  27. 8.5.2 Shineway Pharmaceutical Business Overview
  28. 8.5.3 Shineway Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shineway Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio
  30. 8.5.5 Shineway Pharmaceutical Recent Developments
  31. 8.6 China Resources Sanjiu
  32. 8.6.1 China Resources Sanjiu Company Information
  33. 8.6.2 China Resources Sanjiu Business Overview
  34. 8.6.3 China Resources Sanjiu Qi-Tonifying Chinese Medicine Injections Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 China Resources Sanjiu Qi-Tonifying Chinese Medicine Injections Product Portfolio
  36. 8.6.5 China Resources Sanjiu Recent Developments
  37. 8.7 Sinopharm Yibin Pharmaceutical
  38. 8.7.1 Sinopharm Yibin Pharmaceutical Company Information
  39. 8.7.2 Sinopharm Yibin Pharmaceutical Business Overview
  40. 8.7.3 Sinopharm Yibin Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sinopharm Yibin Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio
  42. 8.7.5 Sinopharm Yibin Pharmaceutical Recent Developments
  43. 8.8 Dali Pharmaceutical
  44. 8.8.1 Dali Pharmaceutical Company Information
  45. 8.8.2 Dali Pharmaceutical Business Overview
  46. 8.8.3 Dali Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Dali Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio
  48. 8.8.5 Dali Pharmaceutical Recent Developments
  49. 8.9 Changshu Leiyunshang Pharmaceutical
  50. 8.9.1 Changshu Leiyunshang Pharmaceutical Company Information
  51. 8.9.2 Changshu Leiyunshang Pharmaceutical Business Overview
  52. 8.9.3 Changshu Leiyunshang Pharmaceutical Qi-Tonifying Chinese Medicine Injections Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Changshu Leiyunshang Pharmaceutical Qi-Tonifying Chinese Medicine Injections Product Portfolio
  54. 8.9.5 Changshu Leiyunshang Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Qi-Tonifying Chinese Medicine Injections Value Chain Analysis
  2. 9.1.1 Qi-Tonifying Chinese Medicine Injections Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Qi-Tonifying Chinese Medicine Injections Sales Mode & Process
  6. 9.2 Qi-Tonifying Chinese Medicine Injections Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Qi-Tonifying Chinese Medicine Injections Distributors
  9. 9.2.3 Qi-Tonifying Chinese Medicine Injections Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.